News | November 14, 2025
LANXESS set to showcase cutting-edge infection control solutions
LANXESS will highlight its commitment to combatting antimicrobial resistance by presenting science-based disinfection solutions
LANXESS will highlight its commitment to combatting antimicrobial resistance by presenting science-based disinfection solutions
Hyaluronic acid is among the world's most valuable biopolymers, with applications spanning from dermal fillers and wound healing to drug delivery and tissue engineering
The data highlight sustained intraocular pressure (IOP) reduction, drop-free treatment outcomes, and strong visual performance
The high-performance polymer’s transparency and biocompatibility support precise implantation and long-term reliability
The new MimixTM GeniTM reference standards were developed from the extensively tested Genome-in-a-Bottle Consortium (GIAB) cell line
The results demonstrated meaningful reductions in the severity of involuntary movements and notable improvements in patient-reported quality of life
Sales from Novo’s GLP-1 portfolio—including Wegovy for obesity and Ozempic for type 2 diabetes reached $5.6 billion
The discussions come as part of the administration’s broader efforts to drive down drug prices and increase patient access to essential therapies
The company plans to use the funds to enhance its technology and forge new strategic partnerships with surgical robotics companies
Senores Pharmaceuticals (SPI) acquired 51% stake in Zoraya Pharmaceuticals
Subscribe To Our Newsletter & Stay Updated
